November 12, 2014
Notes: Beyer, G
Lerch, M M
Dtsch Med Wochenschr. 2013 Nov;138(46):2359-70; quiz 2371-4. doi: 10.1055/s-0033-1349475. Epub 2013 Nov 5.
Author Address: Klinik fur Innere Medizin A, Universitatsmedizin Greifswald, Ernst-Moritz-Arndt-Universitat Greifswald.
Reference Type: Journal Article
Record Number: 4618Author: Bhandari, V., Jaipuria, J., Singh, M. and Chawla, A. S.
Title: Intra-abdominal pressure in the early phase of severe acute pancreatitis: canary in a coal mine? Results from a rigorous validation protocol
Journal: Gut Liver
Short Title: Intra-abdominal pressure in the early phase of severe acute pancreatitis: canary in a coal mine? Results from a rigorous validation protocol
Alternate Journal: Gut and liver
ISSN: 2005-1212 (Electronic)
Accession Number: 24312716
Length of Stay
Multiple Organ Failure/etiology
Severity of Illness Index
Systemic Inflammatory Response Syndrome/etiology
Abstract: BACKGROUND/AIMS: Intra-abdominal hypertension (IAH) is being increasingly reported in patients with severe acute pancreatitis (SAP) with worsened outcomes. The present study was undertaken to evaluate intra-abdominal pressure (IAP) as a marker of severity in the entire spectrum of acute pancreatitis and to ascertain the relationship between IAP and development of complications in patients with SAP. METHODS: IAP was measured via the transvesical route by measurements performed at admission, once after controlling pain and then every 4 hours. Data were collected on the length of the hospital stay, the development of systemic inflammatory response syndrome (SIRS), multiorgan failure, the extent of necrosis, the presence of infection, pleural effusion, and mortality. RESULTS: In total, 40 patients were enrolled and followed up for 30 days. The development of IAH was exclusively associated with SAP with an APACHE II score >/=8 and/or persistent SIRS, identifying all patients who were going to develop abdominal compartment syndrome (ACS). The presence of ACS was associated with a significantly increased extent of pancreatic necrosis, multiple organ failure, and mortality. The mean admission IAP value did not differ significantly from the value obtained after pain control or the maximum IAP measured in the first 5 days. CONCLUSIONS: IAH is reliable marker of severe disease, and patients who manifest organ failure, persistent SIRS, or an Acute Physiology and Chronic health Evaluation II score >/=8 should be offered IAP surveillance. Severe pancreatitis is not a homogenous entity.